Literature DB >> 10630104

Barbarin as a new tyrosinase inhibitor from Barbarea orthocerus.

B Seo1, J Yun, S Lee, M Kim, K Hwang, J Kim, K R Min, Y Kim, D Moon.   

Abstract

A tyrosinase inhibitor was isolated from the whole plant of Barbarea orthocerus Led. (Brassicaceae) by activity-guided fractionation, and identified as (R)-5-phenyl-2-oxazolidinethione (barbarin) by structural analysis followed by comparison with reported spectral data. The compound exhibited significant inhibitory effects on mushroom and murine tyrosinases at more than 1.6 x 10(-5) M. Barbarin exhibited IC50 values of 4.2 x 10(-5) M on mushroom tyrosinase and of 4.8 x 10(-5) M on murine tyrosinase. Kojic acid as a positive control exhibited IC50 values of 3.4 x 10(-5) M and 6.0 x 10(-5) M on mushroom and murine tyrosinases, respectively. Therefore, barbarin exhibited a similar level of inhibitory potency with kojic acid used as a positive control. In a kinetic study with various concentrations of L-dopa as the substrate, barbarin was identified as an uncompetitive inhibitor and kojic acid as a mixed inhibitor of both mushroom and murine tyrosinases. Barbarin exhibited KEIS values of 3.3 x 10(-5) M and 3.6 x 10(-5) M on mushroom and murine tyrosinases, respectively. Kojic acid exhibited KEIS and KEI values of 2.4 x 10(-5) M and 2.2 x 10(-5) M on mushroom tyrosinase and those of 8.9 x 10(-5) M and 7.2 x 10(-5) M on murine tyrosinase, respectively.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10630104     DOI: 10.1055/s-1999-14092

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  2 in total

Review 1.  A comprehensive review on tyrosinase inhibitors.

Authors:  Samaneh Zolghadri; Asieh Bahrami; Mahmud Tareq Hassan Khan; J Munoz-Munoz; F Garcia-Molina; F Garcia-Canovas; Ali Akbar Saboury
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

2.  Copper-catalyzed S-arylation of Furanose-Fused Oxazolidine-2-thiones.

Authors:  Vilija Kederienė; Jolanta Rousseau; Marie Schuler; Algirdas Šačkus; Arnaud Tatibouët
Journal:  Molecules       Date:  2022-08-30       Impact factor: 4.927

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.